Indium-111 labeled gold nanoparticles for in-vivo molecular targeting.
暂无分享,去创建一个
Thomas Krause | Lorenz Meier | Martin A Walter | M. Walter | C. Olariu | T. Krause | N. Marincek | Q. K. Ng | Quinn K T Ng | Cristina I Olariu | Marcus Yaffee | Vincent F Taelman | Nicolas Marincek | L. Meier | Marcus Yaffee | Nicolas Marincek
[1] Leaf Huang,et al. Nanoparticles evading the reticuloendothelial system: role of the supported bilayer. , 2009, Biochimica et biophysica acta.
[2] J. Frangioni,et al. In Vivo Tracking of Stem Cells for Clinical Trials in Cardiovascular Disease , 2004, Circulation.
[3] Bengt Långström,et al. Positron emission tomography microdosing: a new concept with application in tracer and early clinical drug development , 2003, European Journal of Clinical Pharmacology.
[4] Paschalis Alexandridis,et al. Block copolymer-directed metal nanoparticle morphogenesis and organization , 2011 .
[5] R. Weissleder,et al. Multivalent effects of RGD peptides obtained by nanoparticle display. , 2006, Journal of medicinal chemistry.
[6] Ande Bao,et al. In vivo PET imaging and biodistribution of radiolabeled gold nanoshells in rats with tumor xenografts. , 2010, International journal of pharmaceutics.
[7] Hendrik Engelbrecht,et al. Laminin receptor specific therapeutic gold nanoparticles (198AuNP-EGCg) show efficacy in treating prostate cancer , 2012, Proceedings of the National Academy of Sciences.
[8] Warren C W Chan,et al. Effect of gold nanoparticle aggregation on cell uptake and toxicity. , 2011, ACS nano.
[9] W. Weber,et al. Novel 64Cu- and 68Ga-Labeled RGD Conjugates Show Improved PET Imaging of ανβ3 Integrin Expression and Facile Radiosynthesis , 2011, The Journal of Nuclear Medicine.
[10] Lawrence Tamarkin,et al. Phase I and Pharmacokinetic Studies of CYT-6091, a Novel PEGylated Colloidal Gold-rhTNF Nanomedicine , 2010, Clinical Cancer Research.
[11] R. Hicks,et al. Use of molecular targeted agents for the diagnosis, staging and therapy of neuroendocrine malignancy , 2010, Cancer imaging : the official publication of the International Cancer Imaging Society.
[12] D. Wilbur,et al. Radiohalogens for imaging and therapy. , 2005, Chemical Society reviews.
[13] D. Cheresh,et al. Biosynthetic and functional properties of an Arg-Gly-Asp-directed receptor involved in human melanoma cell attachment to vitronectin, fibrinogen, and von Willebrand factor. , 1987, The Journal of biological chemistry.
[14] P. Perriat,et al. The biodistribution of gold nanoparticles designed for renal clearance. , 2013, Nanoscale.
[15] J. Reubi,et al. Affinity profiles for human somatostatin receptor subtypes SST1–SST5 of somatostatin radiotracers selected for scintigraphic and radiotherapeutic use , 2000, European Journal of Nuclear Medicine.
[16] D. Fernig,et al. Robust ligand shells for biological applications of gold nanoparticles. , 2008, Langmuir : the ACS journal of surfaces and colloids.
[17] M. Bawendi,et al. Renal clearance of quantum dots , 2007, Nature Biotechnology.
[18] W. Cai,et al. 64Cu-Labeled Tetrameric and Octameric RGD Peptides for Small-Animal PET of Tumor αvβ3 Integrin Expression , 2007, Journal of Nuclear Medicine.
[19] Karen L Wooley,et al. Copper-64-alloyed gold nanoparticles for cancer imaging: improved radiolabel stability and diagnostic accuracy. , 2014, Angewandte Chemie.
[20] Ralph Weissleder,et al. Molecular imaging in the clinical arena. , 2005, JAMA.
[21] Raffaella Barone,et al. Experimental facts supporting a red marrow uptake due to radiometal transchelation in 90Y-DOTATOC therapy and relationship to the decrease of platelet counts , 2011, European Journal of Nuclear Medicine and Molecular Imaging.
[22] L. Brannon-Peppas,et al. Nanoparticle and targeted systems for cancer therapy. , 2004, Advanced drug delivery reviews.
[23] I. Velikyan. Molecular Imaging and Radiotherapy: Theranostics for Personalized Patient Management , 2012, Theranostics.
[24] T. M. Day,et al. Luminescent nanobeads: attachment of surface reactive Eu(III) complexes to gold nanoparticles. , 2006, Chemical communications.
[25] J. Slot,et al. A new method of preparing gold probes for multiple-labeling cytochemistry. , 1985, European journal of cell biology.
[26] J. Schlenoff,et al. Aggregation-resistant water-soluble gold nanoparticles. , 2007, Langmuir : the ACS journal of surfaces and colloids.
[27] David E Reichert,et al. Metal complexes as diagnostic tools , 1999 .
[28] Ingeborg Goethals,et al. Nuclear medicine imaging to predict response to radiotherapy: a review. , 2003, International journal of radiation oncology, biology, physics.
[29] M. Walter,et al. The Influence of Different Metal-Chelators on the Biological Profile of Nanoparticles for Gallium-68 Based Molecular Imaging , 2012 .
[30] Piotr Walczak,et al. Personalized nanomedicine advancements for stem cell tracking. , 2012, Advanced drug delivery reviews.
[31] H. Kessler,et al. Radiolabelled RGD peptides for imaging and therapy , 2012, European Journal of Nuclear Medicine and Molecular Imaging.
[32] E. Pauwels,et al. 18F-labeled radiopharmaceuticals for PET in oncology, excluding FDG. , 2000, Nuclear medicine and biology.
[33] J. Marchalonis. An enzymic method for the trace iodination of immunoglobulins and other proteins. , 1969, The Biochemical journal.
[34] Dong Liang,et al. Influence of anchoring ligands and particle size on the colloidal stability and in vivo biodistribution of polyethylene glycol-coated gold nanoparticles in tumor-xenografted mice. , 2009, Biomaterials.
[35] D. Fernig,et al. Determination of size and concentration of gold nanoparticles from UV-vis spectra. , 2007, Analytical chemistry.
[36] Karen Weintraub,et al. Biomedicine: The new gold standard , 2013, Nature.
[37] A. Iagaru,et al. Current concepts and future directions in radioimmunotherapy. , 2010, Current drug discovery technologies.
[38] May D. Wang,et al. In vivo tumor targeting and spectroscopic detection with surface-enhanced Raman nanoparticle tags , 2008, Nature Biotechnology.
[39] M. Hensler,et al. Involvement of tumor cell integrin αvβ3 in hematogenous metastasis of human melanoma cells , 2004, Clinical & Experimental Metastasis.